Kunle Odunsi

19PUBLICATIONS
135CO-AUTHORS
Cancer geneticsQuantum information, computation and communicationCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 28, 2026
Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120.

|Feb 05, 2026
Probing Cellular Activity Via Charge-Sensitive Quantum Nanoprobes.

Uri Zvi, Shivam Mundhra, David Ovetsky

|Jun 25, 2025
NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression.

Thejaswini Giridharan, Sora Suzuki, Anm Nazmul H Khan

|Mar 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors.

Henry G Withers, Junko Matsuzaki, Mark Long

|Dec 05, 2024
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer.

Spencer R Rosario, Mark D Long, Shanmuga Chilakapati

|Oct 07, 2024
Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Danuta Kozbor, Marta Winkler, Nemi Malhotra

Pageof 4

Frequent Collaborators

5 joint publications

Emese Zsiros

3 joint publications

Mark Long

3 joint publications

Junko Matsuzaki

2 joint publications

A J Robert McGray